Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea
1999
No health without mental health
2007 Standout
Leishmaniasis
2018 Standout
Vulvovaginal candidosis
2007 Standout
Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases
2005 Standout
Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion
1992 StandoutNobel
Combination of HIV‐1–Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long‐Term Nonprogression
2005
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
1997
Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus
2002
The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients
2003
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression
2002
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
HIV-associated neurologic disease incidence changes:
2001
Skin Cancers after Organ Transplantation
2003 Standout
Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing Antibody
1987
Kaposi’s sarcoma in liver transplant recipients: Morphological and clinical description
2001
Global cancer statistics
2011 Standout
Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression
1998
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach
2000 StandoutNobel
The growing impact of click chemistry on drug discovery
2003 StandoutNobel
Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infection
1991 StandoutNobel
Resistance to Protease Inhibitors
2001
Echinocandin antifungal drugs
2003 Standout
Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†
2005
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
2002
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: detection of a SIVagm variant from a chacma baboon.
1998
Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells
2003
Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada
2008
Candida‐Specific Systemic Cell‐Mediated Immune Reactivities in Human Immunodeficiency Virus–Positive Persons with Mucosal Candidiasis
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Expression of γ-Glutamyl Transpeptidase Protects Ramos B Cells from Oxidation-induced Cell Death
2001
The pathogenesis ofLeishmania/HIV co-infection: cellular and immunological mechanisms
2003
Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy
2000
HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy
2002
AIDS across Europe, 1994–98: the EuroSIDA study
2000
Periodontal diseases
2005 Standout
Immunoglobulin G and Its Function in the Human Respiratory Tract
1988
Superoxide in Apoptosis
1998
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
2002
Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting
1992
Kaposi's Sarcoma
2000 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
2004
Patterns of A2A Extracellular Adenosine Receptor Expression in Different Functional Subsets of Human Peripheral T Cells. Flow Cytometry Studies with Anti-A2A Receptor Monoclonal Antibodies
1999 StandoutNobel
MONOCYTES ARE TARGET CELLS FOR IL-10 INDUCTION BY HIV-1 NEF PROTEIN
2000
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
2000
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia Complex
1988 Science
Wild Mandrillus sphinx Are Carriers of Two Types of Lentivirus
2001 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Human Immunodeficiency Viruses
1986 StandoutScienceNobel
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
1999
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
2008
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees
1990
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
2006
Reversible Near-Infrared Fluorescent Probe Introducing Tellurium to Mimetic Glutathione Peroxidase for Monitoring the Redox Cycles between Peroxynitrite and Glutathione in Vivo
2013 Standout
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
2006
Principles of laboratory isolation and identification of the human immunodeficiency virus (HIV).
1988
Invasive Candidiasis
2015 Standout
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
1987
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The Changing Incidence of AIDS Events in Patients Receiving Highly Active Antiretroviral Therapy
2005
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Intestinal Intraepithelial Lymphocytes Are Primed for Gamma Interferon and MIP-1β Expression and Display Antiviral Cytotoxic Activity despite Severe CD4+T-Cell Depletion in Primary Simian Immunodeficiency Virus Infection
1998
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Antigenic Variation within the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120: Effects on Chemokine Receptor Utilization
2001
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
2006
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
1991
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
2003
Guidelines for Treatment of Candidiasis
2004 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
1998 Standout
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
2007
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Resistance to Protease Inhibitors
2001
Works of E. B. Helm being referenced
Virological response to protease inhibitor therapy in an HIV clinic cohort
1999
Ex Vivo Induction of Apoptosis in Lymphocytes Is Mediated by Oxidative Stress: Role for Lymphocyte Loss in HIV Infection
1997
Kaposiʼs sarcoma in HIV infection
1998
Itraconazol‐Suspension in der Behandlung HIV‐infizierter Patienten mit Fluconazol‐resistenter oropharyngealer Candida‐Infektion und Soorösophagitis
1996
Intestinale Permeabilität bei Patienten mit erworbenem Immundefekt — Syndrom (AIDS)
1991
Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
1997
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
1997
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load
2000
AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDS
1994
Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS
1986
Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
1994
Restricted IgG Subclass Responses to HTLV-III/LAV and to Cytomegalovirus in Patients with AIDS and Lymphadenopathy Syndrome
1986
Change of Causative Organisms under Antifungal Treatment in Immunosuppressed Patients with HIV‐Infections
1989